Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis

Journal of the American College of Cardiology

Volumn 63, Issue 4, 2014, Pages 329-336

  Blankstein, Ron ^a   Osborne, Michael ^a   Naya, Masanao ^a   Waller, Alfonso ^a   Kim, Chun K ^a   Murthy, Venkatesh L ^a   Kazemian, Pedram ^a   Kwong, Raymond Y ^a   Tokuda, Michifumi ^a   Skali, Hicham ^a   Padera, Robert ^a   Hainer, Jon ^a   Stevenson, William G ^a   Dorbala, Sharmila ^a   Di Carli, Marcelo F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

FDG; PET; prognosis; sarcoidosis; VT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RUBIDIUM 82;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DEATH; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERMETHOD COMPARISON; JAPANESE; LIPID DIET; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SARCOIDOSIS; SEX RATIO; TELEPHONE INTERVIEW; ADVERSE OUTCOME; CARDIAC IMAGING; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DIAGNOSTIC TEST ACCURACY STUDY; HEART DEATH; HEART DISEASE; INTERVIEW; RISK ASSESSMENT;

CARDIAC MAGNETIC RESONANCE IMAGING; CMR; COMPUTED TOMOGRAPHY; CT; EMBX; ENDOMYOCARDIAL BIOPSY; FDG; FLUORODEOXYGLUCOSE; ICD; IMPLANTABLE CARDIAC DEFIBRILLATOR; JAPANESE MINISTRY OF HEALTH AND WELFARE; JMHW; LEFT VENTRICULAR EJECTION FRACTION; LVEF; PET; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RIGHT VENTRICULAR; RV; SARCOIDOSIS; VENTRICULAR TACHYCARDIA; VT;

CARDIOMYOPATHIES; CORONARY CIRCULATION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEART; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RUBIDIUM RADIOISOTOPES; SARCOIDOSIS; STROKE VOLUME; TACHYCARDIA, VENTRICULAR;

EID: 84893185966     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.09.022     Document Type: Article

References (13)

1. K.J. Silverman, G.M. Hutchins, and B.H. Bulkley Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis Circulation 58 1978 1204 1211 (Pubitemid 9092005)
2. L.T. Cooper, K.L. Baughman, and A.M. Feldman et al. The role of endomyocardial biopsy in the management of cardiovascular disease Eur Heart J 28 2007 3076 3093
3. M.R. Patel, P.J. Cawley, and J.F. Heitner et al. Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
4. G. Youssef, E. Leung, and I. Mylonas et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2012 241 248
5. H. Yamagishi, N. Shirai, and M. Takagi et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET J Nucl Med 44 2003 1030 1036 (Pubitemid 39663376)
6. K. Kida, K. Yoneyama, Y. Kobayashi, M. Takano, Y.J. Akashi, and F. Miyake Late gadolinium enhancement on cardiac magnetic resonance images Diagnostic standard and guidelines for sarcoidosis [in Japanese] Jpn J Sarcoidosis Granulomatous Disord 27 2007 89 102
7. S. Ishimaru, I. Tsujino, and T. Takei et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543 (Pubitemid 41373496)
8. P. Ott, F.I. Marcus, R.E. Sobonya, F. Morady, B.P. Knight, and C.E. Fuenzalida Cardiac sarcoidosis masquerading as right ventricular dysplasia. Pacing and clinical electrophysiology Pacing Clin Electrophysiol 26 2003 1498 1503 (Pubitemid 36836702)
9. H. Ohira, I. Tsujino, and S. Ishimaru et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 2008 933 941
10. M.T. Osborne, E.A. Hulten, and A. Singh et al. Reduction in f-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis J Nucl Cardiol 2013 Dec 3 [E-pub ahead of print]
11. J.L. Schuller, M. Zipse, and T. Crawford et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis J Cardiovasc Electophysiol 23 2012 925 929
12. B.P. Betensky, C.M. Tschabrunn, and E.S. Zado et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators Heart Rhythm 9 2012 884 891
13. K.A. Ellenbogen, J.H. Levine, and R.D. Berger et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782